AR011707A1 - Composicion farmaceutica que comprende tirosina y un alergeno opcionalmente modificado, procedimiento para su preparacion y el uso de la misma para la manufactura de un medicamento. - Google Patents
Composicion farmaceutica que comprende tirosina y un alergeno opcionalmente modificado, procedimiento para su preparacion y el uso de la misma para la manufactura de un medicamento.Info
- Publication number
- AR011707A1 AR011707A1 ARP980101508A ARP980101508A AR011707A1 AR 011707 A1 AR011707 A1 AR 011707A1 AR P980101508 A ARP980101508 A AR P980101508A AR P980101508 A ARP980101508 A AR P980101508A AR 011707 A1 AR011707 A1 AR 011707A1
- Authority
- AR
- Argentina
- Prior art keywords
- procedure
- preparation
- pharmaceutical composition
- thyrosine
- manufacture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Una composicion farmacéutica que comprende tirosina, un alérgeno opcionalmente modificado, y lípidos A monofosforilo 3-de-O-acilado, es utilen la prevencion y en el tratamiento de la alergia. Además se describe un procedimiento parapreparar dichas composiciones, y el uso de la misma parala preparacion de un medicamento.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9706957.9A GB9706957D0 (en) | 1997-04-05 | 1997-04-05 | Formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
AR011707A1 true AR011707A1 (es) | 2000-08-30 |
Family
ID=10810358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980101508A AR011707A1 (es) | 1997-04-05 | 1998-04-02 | Composicion farmaceutica que comprende tirosina y un alergeno opcionalmente modificado, procedimiento para su preparacion y el uso de la misma para la manufactura de un medicamento. |
Country Status (17)
Country | Link |
---|---|
US (2) | US7718178B2 (es) |
EP (1) | EP0975364B1 (es) |
JP (1) | JP4331798B2 (es) |
KR (1) | KR100549557B1 (es) |
AR (1) | AR011707A1 (es) |
AT (1) | ATE268607T1 (es) |
AU (1) | AU729631B2 (es) |
CA (1) | CA2285928C (es) |
CO (1) | CO4940482A1 (es) |
DE (1) | DE69824405T2 (es) |
ES (1) | ES2218819T3 (es) |
GB (1) | GB9706957D0 (es) |
NZ (1) | NZ337580A (es) |
PT (1) | PT975364E (es) |
TW (1) | TWI240628B (es) |
WO (1) | WO1998044947A1 (es) |
ZA (1) | ZA982851B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9706957D0 (en) * | 1997-04-05 | 1997-05-21 | Smithkline Beecham Plc | Formulation |
GB9820525D0 (en) | 1998-09-21 | 1998-11-11 | Allergy Therapeutics Ltd | Formulation |
GB0000891D0 (en) | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
CN1775701B (zh) * | 2004-11-16 | 2010-05-26 | 鸿富锦精密工业(深圳)有限公司 | 具有超硬镀膜的模仁 |
GB201106802D0 (en) * | 2011-04-21 | 2011-06-01 | Allergy Therapeutics Ltd | Process for preparing vaccine composition |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1128637A (en) | 1966-09-13 | 1968-09-25 | Beecham Group Ltd | Influenza vaccine |
US3541201A (en) * | 1968-12-18 | 1970-11-17 | Ethan Alan Brown | Novel sodium chloride encapsulated injectionable substances |
GB1377074A (en) * | 1971-07-13 | 1974-12-11 | Beecham Group Ltd | Process for preparing injectable compositions |
US4070455A (en) * | 1974-02-16 | 1978-01-24 | Beecham Group Limited | Process for preparing injectable desensitizing compositions and products thereof in microparticle form |
GB1492973A (en) * | 1974-02-16 | 1977-11-23 | Beecham Group Ltd | Process for preparing injectable compositions |
EP0182442B2 (en) | 1978-12-22 | 1996-04-03 | Biogen, Inc. | Recombinant DNA molecules and their method of production |
US4258029A (en) | 1979-04-23 | 1981-03-24 | Connaught Laboratories Limited | Synthetic adjuvants for stimulation of antigenic responses |
US4528029A (en) * | 1980-07-21 | 1985-07-09 | Board Of Control Of Michigan Technological University | Self-reducing iron oxide agglomerates |
US4987237A (en) * | 1983-08-26 | 1991-01-22 | Ribi Immunochem Research, Inc. | Derivatives of monophosphoryl lipid A |
GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
US5244663A (en) * | 1987-01-28 | 1993-09-14 | Medibrevex | Therapeutic method against allergy |
FR2621916B1 (fr) * | 1987-10-19 | 1990-03-09 | Bioeurope | Derives de la l-tyrosine solubles dans l'eau et procede pour leur preparation |
US4912094B1 (en) * | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
GB9106048D0 (en) | 1991-03-21 | 1991-05-08 | Smithkline Beecham Biolog | Vaccines |
EP0640347A1 (en) | 1992-03-03 | 1995-03-01 | Daiichi Pharmaceutical Co., Ltd. | Oral vaccine |
SK279188B6 (sk) * | 1992-06-25 | 1998-07-08 | Smithkline Beecham Biologicals S.A. | Vakcínová kompozícia spôsob jej prípravy a použiti |
WO1994021292A1 (en) * | 1993-03-23 | 1994-09-29 | Smithkline Beecham Biologicals (S.A.) | Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
JP3734263B2 (ja) | 1993-05-25 | 2006-01-11 | ワイス・ホールディングズ・コーポレイション | 呼吸器シンシチウムウイルスに対するワクチンのためのアジュバント |
EP0719155A1 (en) | 1993-08-27 | 1996-07-03 | Enteric Research Laboratories, Inc. | $i(CAMPYLOBACTER JEJUNI) ANTIGENS, AND METHODS FOR THEIR PRODUCTION AND USE |
GB9326253D0 (en) * | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
US5997873A (en) * | 1994-01-13 | 1999-12-07 | Mount Sinai School Of Medicine Of The City University Of New York | Method of preparation of heat shock protein 70-peptide complexes |
US5646115A (en) * | 1994-10-07 | 1997-07-08 | Heska Corporation | Ectoparasite saliva proteins and apparatus to collect such proteins |
AU4977896A (en) | 1995-02-17 | 1996-09-04 | Immunotherapy, Inc. | Immunotherapy screening, prognosis, and treatment methods and compositions |
GB9508785D0 (en) * | 1995-04-29 | 1995-06-21 | Smithkline Beecham Plc | Novel compositions |
US5762943A (en) * | 1996-05-14 | 1998-06-09 | Ribi Immunochem Research, Inc. | Methods of treating type I hypersensitivity using monophosphoryl lipid A |
US5973128A (en) * | 1996-11-22 | 1999-10-26 | The Hospital For Sick Children Research And Development Lp | Glycolipid mimics and methods of use thereof |
US6491919B2 (en) | 1997-04-01 | 2002-12-10 | Corixa Corporation | Aqueous immunologic adjuvant compostions of monophosphoryl lipid A |
CN1259052A (zh) | 1997-04-01 | 2000-07-05 | 科里克萨有限公司 | 单磷酰基脂质a的水性免疫佐剂组合物 |
GB9706957D0 (en) * | 1997-04-05 | 1997-05-21 | Smithkline Beecham Plc | Formulation |
AU7983198A (en) | 1997-06-23 | 1999-01-04 | Ludwig Institute For Cancer Research | Improved methods for inducing an immune response |
GB9717953D0 (en) | 1997-08-22 | 1997-10-29 | Smithkline Beecham Biolog | Vaccine |
GB9720585D0 (en) | 1997-09-26 | 1997-11-26 | Smithkline Beecham Biolog | Vaccine |
AU750173B2 (en) | 1997-11-10 | 2002-07-11 | Statens Serum Institut | Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis |
GB9812613D0 (en) | 1998-06-11 | 1998-08-12 | Smithkline Beecham Biolog | Vaccine |
CA2330209A1 (en) | 1998-06-12 | 1999-12-23 | Smithkline Beecham Biologicals S.A. | Recombinant production of toxoplasma sag1 antigen |
GB9820525D0 (en) | 1998-09-21 | 1998-11-11 | Allergy Therapeutics Ltd | Formulation |
US6734172B2 (en) | 1998-11-18 | 2004-05-11 | Pacific Northwest Research Institute | Surface receptor antigen vaccines |
EP1031347B1 (en) | 1999-01-27 | 2002-04-17 | Idea Ag | Transnasal transport/immunisation with highly adaptable carriers |
DE69942774D1 (de) | 1999-02-26 | 2010-10-28 | Novartis Vaccines & Diagnostic | Verwendung von bioadhaesiven und adjuvantien für die mukosale anwendung von antigenen |
GB9909077D0 (en) | 1999-04-20 | 1999-06-16 | Smithkline Beecham Biolog | Novel compositions |
EE200100552A (et) | 1999-04-23 | 2002-12-16 | Pharmexa A/S | Meetod kasvuteguri IL-5 aktiivsuse in vivo mahasurumiseks, IL-5 analoog, seda kodeeriv nukleiinhappefragment ning kasutamine immunogeense kompositsiooni valmistamiseks |
UA81216C2 (en) | 1999-06-01 | 2007-12-25 | Prevention and treatment of amyloid disease | |
GB9924529D0 (en) | 1999-10-15 | 1999-12-15 | Smithkline Beecham Biolog | Novel compounds |
GB0000891D0 (en) | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
-
1997
- 1997-04-05 GB GBGB9706957.9A patent/GB9706957D0/en active Pending
-
1998
- 1998-04-02 AR ARP980101508A patent/AR011707A1/es active IP Right Grant
- 1998-04-03 WO PCT/EP1998/002138 patent/WO1998044947A1/en active IP Right Grant
- 1998-04-03 DE DE69824405T patent/DE69824405T2/de not_active Expired - Lifetime
- 1998-04-03 KR KR1019997008719A patent/KR100549557B1/ko not_active IP Right Cessation
- 1998-04-03 AU AU72160/98A patent/AU729631B2/en not_active Expired
- 1998-04-03 JP JP54240898A patent/JP4331798B2/ja not_active Expired - Lifetime
- 1998-04-03 EP EP98919258A patent/EP0975364B1/en not_active Expired - Lifetime
- 1998-04-03 CO CO98018888A patent/CO4940482A1/es unknown
- 1998-04-03 ES ES98919258T patent/ES2218819T3/es not_active Expired - Lifetime
- 1998-04-03 ZA ZA9802851A patent/ZA982851B/xx unknown
- 1998-04-03 PT PT98919258T patent/PT975364E/pt unknown
- 1998-04-03 AT AT98919258T patent/ATE268607T1/de active
- 1998-04-03 NZ NZ337580A patent/NZ337580A/en not_active IP Right Cessation
- 1998-04-03 CA CA002285928A patent/CA2285928C/en not_active Expired - Lifetime
- 1998-04-07 TW TW087105161A patent/TWI240628B/zh not_active IP Right Cessation
-
2005
- 2005-01-21 US US11/040,952 patent/US7718178B2/en not_active Expired - Fee Related
-
2010
- 2010-03-29 US US12/749,326 patent/US8105605B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NZ337580A (en) | 2001-04-27 |
ES2218819T3 (es) | 2004-11-16 |
WO1998044947A1 (en) | 1998-10-15 |
US8105605B2 (en) | 2012-01-31 |
US7718178B2 (en) | 2010-05-18 |
EP0975364A1 (en) | 2000-02-02 |
EP0975364B1 (en) | 2004-06-09 |
DE69824405T2 (de) | 2004-10-07 |
US20050123570A1 (en) | 2005-06-09 |
CO4940482A1 (es) | 2000-07-24 |
CA2285928C (en) | 2008-07-08 |
ZA982851B (en) | 1999-10-04 |
KR100549557B1 (ko) | 2006-02-08 |
AU729631B2 (en) | 2001-02-08 |
GB9706957D0 (en) | 1997-05-21 |
US20100183659A1 (en) | 2010-07-22 |
ATE268607T1 (de) | 2004-06-15 |
JP2001519797A (ja) | 2001-10-23 |
KR20010005651A (ko) | 2001-01-15 |
DE69824405D1 (de) | 2004-07-15 |
TWI240628B (en) | 2005-10-01 |
AU7216098A (en) | 1998-10-30 |
PT975364E (pt) | 2004-09-30 |
JP4331798B2 (ja) | 2009-09-16 |
CA2285928A1 (en) | 1998-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9808888A (pt) | Formas de dosagem e método de melhorar disfunção erétil masculina | |
AR004700A1 (es) | 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento | |
ES2159382T3 (es) | Compuestos estilbenicos con grupo adamantilo, composiciones que los contienen y utilizaciones. | |
AR033548A1 (es) | Composicion farmaceutica que comprende un inhibidor de lipasa, un procedimiento para su preparacion, equipo transportable a modo de ''kit'', el uso de dicha composicion en la fabricacion de medicamentos, un inhibidor de lipasa y un secuestrante de acidos biliares | |
AR002754A1 (es) | Composición farmacéutica que comprende bacterias lactobacillus viables micro-encapsuladas, y uso de la composición para preparar de un medicamento | |
CL2004001191A1 (es) | Compuestos derivados de esteroides 17 alpha-fluoroalquilados, con actividad antigestagena; composicion farmaceutica; combinacion farmaceutica; y uso del compuesto en la preparacion de un medicamento antiestrogenico, para el tratamiento de dismenorrea | |
HUP9904174A2 (hu) | Bőrön át történő adagoláshoz szánt gyógyszerkészítmények | |
SV2004001556A (es) | Preparaciones acidas de insulina con establidad mejorada | |
AR016798A1 (es) | Uso de una cepa de lactobacillus para la elaboracion de un medicamento | |
AR052921A1 (es) | Uso de ranolazina para la preparacion de una composicion farmaceutica y composicion farmaceutica | |
MX9204268A (es) | Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma. | |
ES2178430T3 (es) | Utilizacion de composiciones farmaceuticas gelificables en parodontologia. | |
DE60115029D1 (de) | Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate | |
ES2080307T3 (es) | Composiciones farmaceuticas. | |
AR023806A1 (es) | Uso de una mezcla de peptidos para la manufactura de un agente terapeutico para la profilaxis y/o el tratamiento del cancer, las composicionesfarmaceuticas y vacunas que contienen dicha mezcla y los procedimientos de preparacion de dichas composiciones y vacunas | |
AR012125A1 (es) | UNA SAL DE UN COMPUESTO DERIVADO DEL ÁCIDO NAFTIRIDINA CARBOXíLICO , SU USO PARA LA FABRICACIoN DE UN MEDICAMENTO , PROCEDIMIENTO PARA PREPARARLA Y UNA COMPOSICIoN FARMACÉUTICA QUE LO COMPRENDE | |
HK1068606A1 (en) | Novel aminobenzoephenones | |
AR024564A1 (es) | Composicion que comprende esfingomielinasa para el uso como una preparacion dietetica, suplemento dietario o producto farmaceutico | |
AR015966A1 (es) | Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito | |
BR0107899A (pt) | Processo para produzir uma preparação de ingrediente ativo compreendendo ibuprofeno, preparação de ingrediente ativo, uso da mesma, preparação farmacêutica, uso da mesma, processo para produzir formas de dosagem sólidas, e, forma de dosagem sólida | |
AR023687A1 (es) | Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa | |
ATE464878T1 (de) | Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl | |
AR001765A1 (es) | Una formulación de liberación prolongada un procedimiento para su preparación una forma cristalina de cisaprida-(l)-tartrato y un medicamento util para el tratamiento de trastornos gastrointestinales | |
AR011707A1 (es) | Composicion farmaceutica que comprende tirosina y un alergeno opcionalmente modificado, procedimiento para su preparacion y el uso de la misma para la manufactura de un medicamento. | |
DE60202590D1 (de) | 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |